Cargando…

Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis

Congenital nephrogenic diabetes insipidus (CNDI) is a genetic disorder caused by mutations in arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 genes, rendering collecting duct cells insensitive to the peptide hormone arginine vasopressin stimulation for water reabsorption. This study reports a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ming-Chun, Hsiao, Yu-Chao, Chang, Chun-Chun, Pan, Sheng-Feng, Peng, Chih-Wen, Li, Ya-Tzu, Liu, Cheng-Der, Liou, Je-Wen, Hsu, Hao-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002004/
https://www.ncbi.nlm.nih.gov/pubmed/33804115
http://dx.doi.org/10.3390/biomedicines9030301
_version_ 1783671362229895168
author Chen, Ming-Chun
Hsiao, Yu-Chao
Chang, Chun-Chun
Pan, Sheng-Feng
Peng, Chih-Wen
Li, Ya-Tzu
Liu, Cheng-Der
Liou, Je-Wen
Hsu, Hao-Jen
author_facet Chen, Ming-Chun
Hsiao, Yu-Chao
Chang, Chun-Chun
Pan, Sheng-Feng
Peng, Chih-Wen
Li, Ya-Tzu
Liu, Cheng-Der
Liou, Je-Wen
Hsu, Hao-Jen
author_sort Chen, Ming-Chun
collection PubMed
description Congenital nephrogenic diabetes insipidus (CNDI) is a genetic disorder caused by mutations in arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 genes, rendering collecting duct cells insensitive to the peptide hormone arginine vasopressin stimulation for water reabsorption. This study reports a first identified AVPR2 mutation in Taiwan and demonstrates our effort to understand the pathogenesis caused by applying computational structural analysis tools. The CNDI condition of an 8-month-old male patient was confirmed according to symptoms, family history, and DNA sequence analysis. The patient was identified to have a valine 279 deletion–mutation in the AVPR2 gene. Cellular experiments using mutant protein transfected cells revealed that mutated AVPR2 is expressed successfully in cells and localized on cell surfaces. We further analyzed the pathogenesis of the mutation at sub-molecular levels via long-term molecular dynamics (MD) simulations and structural analysis. The MD simulations showed while the structure of the extracellular ligand-binding domain remains unchanged, the mutation alters the direction of dynamic motion of AVPR2 transmembrane helix 6 toward the center of the G-protein binding site, obstructing the binding of G-protein, thus likely disabling downstream signaling. This study demonstrated that the computational approaches can be powerful tools for obtaining valuable information on the pathogenesis induced by mutations in G-protein-coupled receptors. These methods can also be helpful in providing clues on potential therapeutic strategies for CNDI.
format Online
Article
Text
id pubmed-8002004
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80020042021-03-28 Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis Chen, Ming-Chun Hsiao, Yu-Chao Chang, Chun-Chun Pan, Sheng-Feng Peng, Chih-Wen Li, Ya-Tzu Liu, Cheng-Der Liou, Je-Wen Hsu, Hao-Jen Biomedicines Article Congenital nephrogenic diabetes insipidus (CNDI) is a genetic disorder caused by mutations in arginine vasopressin receptor 2 (AVPR2) or aquaporin 2 genes, rendering collecting duct cells insensitive to the peptide hormone arginine vasopressin stimulation for water reabsorption. This study reports a first identified AVPR2 mutation in Taiwan and demonstrates our effort to understand the pathogenesis caused by applying computational structural analysis tools. The CNDI condition of an 8-month-old male patient was confirmed according to symptoms, family history, and DNA sequence analysis. The patient was identified to have a valine 279 deletion–mutation in the AVPR2 gene. Cellular experiments using mutant protein transfected cells revealed that mutated AVPR2 is expressed successfully in cells and localized on cell surfaces. We further analyzed the pathogenesis of the mutation at sub-molecular levels via long-term molecular dynamics (MD) simulations and structural analysis. The MD simulations showed while the structure of the extracellular ligand-binding domain remains unchanged, the mutation alters the direction of dynamic motion of AVPR2 transmembrane helix 6 toward the center of the G-protein binding site, obstructing the binding of G-protein, thus likely disabling downstream signaling. This study demonstrated that the computational approaches can be powerful tools for obtaining valuable information on the pathogenesis induced by mutations in G-protein-coupled receptors. These methods can also be helpful in providing clues on potential therapeutic strategies for CNDI. MDPI 2021-03-15 /pmc/articles/PMC8002004/ /pubmed/33804115 http://dx.doi.org/10.3390/biomedicines9030301 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Article
Chen, Ming-Chun
Hsiao, Yu-Chao
Chang, Chun-Chun
Pan, Sheng-Feng
Peng, Chih-Wen
Li, Ya-Tzu
Liu, Cheng-Der
Liou, Je-Wen
Hsu, Hao-Jen
Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title_full Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title_fullStr Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title_full_unstemmed Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title_short Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis
title_sort valine-279 deletion–mutation on arginine vasopressin receptor 2 causes obstruction in g-protein binding site: a clinical nephrogenic diabetes insipidus case and its sub-molecular pathogenic analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002004/
https://www.ncbi.nlm.nih.gov/pubmed/33804115
http://dx.doi.org/10.3390/biomedicines9030301
work_keys_str_mv AT chenmingchun valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT hsiaoyuchao valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT changchunchun valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT panshengfeng valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT pengchihwen valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT liyatzu valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT liuchengder valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT lioujewen valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis
AT hsuhaojen valine279deletionmutationonargininevasopressinreceptor2causesobstructioningproteinbindingsiteaclinicalnephrogenicdiabetesinsipiduscaseanditssubmolecularpathogenicanalysis